Showing 51-60 of 936 results for "".
Genetic Testing in the Care of Patients With Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/genetic-testing-in-the-care-of-patients-with-epilepsy/30184/Genetic testing is improving diagnostic accuracy and, sometimes, informing treatment decisions.Migraine and the Presidency: Clinical Lessons from History?
https://practicalneurology.com/columns/practice-management/migraine-and-the-presidency-clinical-lessons-from-history/30790/History reveals some interesting facts about migraine, perceptions of chronic headaches, and the impact of migraine on the power to leadSafety Monitoring of Disease-Modifying Therapies in Multiple Sclerosis
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/safety-monitoring-of-disease-modifying-therapies-in-multiple-sclerosis/32085/Guidance in disease-modifying therapy selection and appropriate safety monitoring are important roles of the clinician caring for people with multiple sclerosis.Long-Term Neurologic Complications of COVID-19: A Practical Overview
https://practicalneurology.com/diseases-diagnoses/imaging-testing/long-term-neurologic-complications-of-covid-19-a-practical-overview/32150/The authors present an overview of the presentation and management of common neurologic symptoms associated with long COVID.Epilepsy Essentials: Physical Activity and Epilepsy
https://practicalneurology.com/diseases-diagnoses/epilepsy-seizures/epilepsy-essentials-physical-activity-and-epilepsy/31775/Neurologists can be comfortable prescribing exercise as part of an overall health plan for people with epilepsy.Myasthenia Gravis Treatment
https://practicalneurology.com/diseases-diagnoses/neuromuscular/myasthenia-gravis-treatment/31553/Both symptomatic and maintenance treatments are available.- News Briefshttps://practicalneurology.com/columns/practice-management/news-briefs/31327/Thousands of neurologists gathered at the San Diego Convention Center from April 1-8 for the American Academy of Neurology’s (AAN) annual conference, fostering extensive collaboration across subspecialties. Among the key highlights were the release of four new evidence-based practice parameters for
Movement Disorders Moment: Personalized Medicine in Parkinson Disease
https://practicalneurology.com/archives/aug-2025-issue/personalized-medicine-in-parkinson-disease/36699/Pharmacogenetic testing provides a promising path to personalizing treatments for individuals living with Parkinson disease.MS Minute: Retinal Optical Coherence Tomography for MS
https://practicalneurology.com/diseases-diagnoses/ms-immune-disorders/ms-minute-retinal-optical-coherence-tomography-for-ms/31939/How optical coherence tomography interpretation can aid care for multiple sclerosis.Clinical Use of Dementia Biomarkers to Evaluate Cognitive Deficits in People With Primary Psychiatric Disorders
https://practicalneurology.com/diseases-diagnoses/alzheimer-disease-dementias/clinical-use-of-dementia-biomarkers-to-evaluate-cognitive-deficits-in-people-with-primary-psychiatric-disorders/32101/Biomarkers may assist in identifying whether symptoms are the result of the primary psychiatric process or a neurodegenerative process.